Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 7/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 7/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 7/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 6/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.33 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.33 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28630993 | 1.00 | SMN1; SMN2 (0.38) | SMN1; SMN2KMT2AHDAC3HDAC1HDAC10 | |
| SCHEMBL1508845 | 1.00 | SMN1; SMN2 (0.38) | SMN1; SMN2KMT2AHDAC3HDAC1HDAC10 | |
| SCHEMBL13257737 | 0.93 | KMT2A (0.33) | SMN1; SMN2KMT2AFOLH1PSMB8PSMB5 | |
| SCHEMBL37833 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTALDH1A1 | |
| SCHEMBL905404 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTALDH1A1 | |
| SCHEMBL1870550 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTALDH1A1 | |
| SCHEMBL905722 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTALDH1A1 | |
| SCHEMBL4960230 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTALDH1A1 | |
| SCHEMBL16983769 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTALDH1A1 | |
| SCHEMBL905700 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230132381-A9 | SYNTHESIS OF FUNCTIONALIZABLE OR FUNCTIONALIZED POLY(3,4-ETHYLENEDIOXYTHIPHENE)-BASED POLYMERS AND MONOMERS THEREFOR | PITTSBURGH, UNIVERSITY OF - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2023-04-27 | — | — | US | claimed |
| US-20250052675-A1 | Attenuated Total Reflectance-Based Biosensor for Conformation and Secondary Structure Analysis | BETASENSE GMBH (DE) | 2025-02-13 | — | — | US | disclosed |
| EP-3305853-B1 | DISPERSION | ASAHI CHEMICAL IND (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-20240201198-A1 | COMPOSITIONS, METHODS, AND UTILITY OF CONJUGATED BIOMOLECULE BARCODES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-06-20 | — | — | US | disclosed |
| EP-3631446-B1 | BIOSENSOR FOR CONFORMATION AND SECONDARY STRUCTURE ANALYSIS | BETASENSE GMBH (DE) | 2024-04-17 | — | — | EP | disclosed |
| EP-4348267-A2 | COMPOSITIONS, METHODS, AND UTILITY OF CONJUGATED BIOMOLECULE BARCODES | Board of Regents, The University of Texas System (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20230132381-A9 | SYNTHESIS OF FUNCTIONALIZABLE OR FUNCTIONALIZED POLY(3,4-ETHYLENEDIOXYTHIPHENE)-BASED POLYMERS AND MONOMERS THEREFOR | PITTSBURGH, UNIVERSITY OF - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2023-04-27 | — | — | US | disclosed |
| WO-2022251457-A2 | COMPOSITIONS, METHODS, AND UTILITY OF CONJUGATED BIOMOLECULE BARCODES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-12-01 | — | — | WO | disclosed |
| US-11237176-B2 | Infrared assay detecting secondary structure profiles of alpha-synuclein | PROTHENA BIOSCIENCES LIMITED (IE) | 2022-02-01 | — | — | US | disclosed |
| EP-3943942-A1 | BIOSENSOR FOR CONFORMATION AND SECONDARY STRUCTURE ANALYSIS | betaSENSE GmbH (DE) | 2022-01-26 | — | — | EP | disclosed |
| US-20160313313-A1 | LATERAL FLOW ASSAY APPARATUS AND METHOD, AND SENSOR THERFOR | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230132381-A9 | SYNTHESIS OF FUNCTIONALIZABLE OR FUNCTIONALIZED POLY(3,4-ETHYLENEDIOXYTHIPHENE)-BASED POLYMERS AND MONOMERS THEREFOR | SLC6A11, KCNT1, SLC39A11 | SMN1; SMN2 4768/4885KMT2A 593/4885HDAC3 1014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.